Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Sep 6, 2018
    Sanofi To Pay $25 Million To Settle SEC Case
  • Aug 31, 2018
    District Court Allows Insurance Fraud Case Against Insys To Proceed
  • Aug 29, 2018
    Pfizer Requests FDA Guidance on Biosimilar Communications
  • Aug 29, 2018
    Canadian Province Sues Opioid Makers
  • Aug 28, 2018
    OPDP Releases Fourth Untitled Letter for 2018
  • Aug 27, 2018
    Two Senators Question Giuliani Involvement in DOJ-DEA Investigations of Purdue Pharma
  • Aug 24, 2018
    NAD Refers Cold Sore Claim to FDA and FTC
  • Aug 24, 2018
    Senate Adds DTC Price Listing Amendment To HHS Appropriations Bill
  • Aug 23, 2018
    Companies Battle Before NAD Over ‘Dry Mouth’ and ‘Saliva Substitute’ Products
  • Aug 22, 2018
    District Court Allows Lawsuit Questioning Whether a 510(k) Device Can Be Advertised as FDA-Approved
  • More

Good Clinical Practice

  • Nov 8, 2018
    Better Guidelines Needed for Including Pregnant Women in Clinical Trials
  • Nov 8, 2018
    FDA Issues Final Guidance for Developing Combo Approved Drugs for Hypertension
  • Nov 7, 2018
    FDA Issues Guidance on Meta-analysis for Safety Concerns
  • Nov 7, 2018
    FDA Posts MyStudies App Links
  • Nov 6, 2018
    Cancer Groups Release Recommendations for Immune-Oncology Trial Reporting
  • Nov 5, 2018
    Trial Database Launched
  • Nov 5, 2018
    Senators Urge NIH to Update Guidance on Minority Group Inclusion in Clinical Trials
  • Nov 1, 2018
    FDA Issues Guidance on Trials To Assess Drug Testicular Toxicity Risks
  • Nov 1, 2018
    FDA Releases Draft Guidance on Using MRD as Trial Biomarker
  • Nov 1, 2018
    ACRP To Develop Principal Investigator Competence Standards
  • More

U.S. Food Labeling

  • Nov 12,2014
    AMS Final Rule Paves Way for Fee Formula
  • Nov 5,2014
    GMO Labeling Measure in Oregon Poised for Defeat in Close Election
  • Nov 5,2014
    Colorado’s GMO Labeling Ballot Initiative Goes Down in Flames
  • Oct 30,2014
    FDA Says the Most Common Cause for Allergen-based Recalls Is Mislabeling
  • Oct 28,2014
    USDA Guidance Outlines Procedures for Making Non-GMO Labeling Claims on Organic Foods
  • Oct 24,2014
    FDA Must Develop Final GRAS Rule Before September 2016 Under Consent Decree
  • Oct 22,2014
    WTO Panel: COOL Rule Changes Violate International Trade Accords
  • Oct 20,2014
    Perdue Farms Drops ‘Humanely Raised’ Claims Under a Settlement with the Humane Society
  • Oct 18,2014
    Vt. Unveils Proposed Rules for GMO Labeling
  • Oct 15,2014
    Cash Pours in for Proponents, Opponents of Oregon’s GMO Food Labeling Measure
  • More

FDA Regulation & Enforcement

  • Dec 9, 2021
    Allergan Settles with New York over Opioid Marketing
  • Dec 9, 2021
    FDA Is Asking for Input on Use of NAC as Dietary Supplement
  • Dec 8, 2021
    Trade Group Asks Court To Bar FDA from Asserting that Dietary Supplement Is an Unapproved Drug
  • Dec 3, 2021
    OIG Opinion OKs Sponsor Picking Up Medicare Beneficiary Costs in Clinical Trial
  • Dec 2, 2021
    DOJ: French Citizen Made False Statements to FDA To Fraudulently Obtain Control of Weight Loss Drug
  • Dec 1, 2021
    OIG Will Not Sanction Drug Maker’s Arrangement with Hospitals
  • Nov 23, 2021
    FDA Conducted Twice the Number of Domestic Inspections It Had Projected for Fiscal Year 2021
  • Nov 22, 2021
    DOJ: Orthopedic Device Development Royalties Dispute with Surgeon Evolved into Illegal Kickback Scheme
  • Nov 21, 2021
    Meeting Archive Available on Toxic Elements in Baby Food
  • Nov 21, 2021
    Recordings From Food E-Commerce Summit Available
  • More

Medical Devices

  • Jun 21, 2017
    Medtronic Dodges False Claims Suit Alleging that Customer Support Services Were Illegal Kickbacks
  • Jun 14, 2017
    FDA Issues Closeout Letter for QS Allegations in 2015 Warning Letter to Zimmer Biomet
  • Jun 9, 2017
    Some Reusable Device 510(k)s To Require Validated Instructions for Use, Reprocessing Validation Data
  • Jun 2, 2017
    FDA Announces Intention to Extend UDI Compliance Dates for Class I, Unclassified Devices
  • May 31, 2017
    Task Force To Report Device, Health Care IT Cybersecurity Recommendations to Congress
  • May 31, 2017
    Survey: Few Device Manufacturers Are Taking ‘Significant Steps’ To Prevent Cyberattacks
  • May 24, 2017
    Bill Would Allow Alternative Way for Device Sponsors To Establish Substantial Equivalence
  • May 16, 2017
    FDA To Design Pilot Program for Assessing Device Conformance with Recognized Consensus Standards
  • May 11, 2017
    FDA Gears Up To Implement Device Provisions of Cures Act With Proposed Work Plan
  • May 9, 2017
    Gottlieb Confirmed by Senate as New FDA Commissioner
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.